enGene Announces That It Has Agreed To Sell 6,758,311 Of Its Common Shares At A Price Per Share Of $8.90; Anticipates The Gross Proceeds From The Private Placement To Be ~$60M
Portfolio Pulse from Benzinga Newsdesk
enGene Holdings Inc. (NASDAQ:ENGN) has announced a private placement of 6,758,311 common shares at $8.90 per share, expecting to raise approximately $60 million. The financing is set to close on October 29, 2024, with participation from several investment firms.

October 25, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
enGene Holdings Inc. is conducting a private placement of 6,758,311 shares at $8.90 each, aiming to raise $60 million. This move could provide the company with significant capital to advance its clinical-stage genetic medicines.
The private placement will provide enGene with substantial funds, potentially enhancing its financial stability and ability to progress its clinical trials. This is likely to be viewed positively by investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100